a1-antitrypsin. Reactions were also obtained with the IgG in 43 and IgA in 21 cases, showing the presence of specific IgG and IgA antibody against the enzymes. No IgA reactions were obtained without an associated IgG reaction. It was not possible to show IgM antibody. In tests on 18 cord-blood sera, 30 blood bank sera, 42 nonconsumers, 48 light and 48 heavy consumers, reactions were produced with the O2-macroglobulin and ocl-antitrypsin but not with IgG or IgA.
Conclusions
The findings show that at least two-thirds of the factory workers had been adequately enough exposed to the B. subtilis enzymes for the stimulation of IgG and IgA antibodies, which were not found in the consumers. The presence, however, of IgE antibody to the enzymes seems more relevant to the clinical manifestations, and since this is more readily produced by atopic subjects, this group needs particular attention. The possible contribution to the clinical findings of the sensitivity of the atopic subjects to common allergens must also be taken into account in trying to assess the influence of the patient's occupation, particularly where exposure to the enzyme preparations may be at a very low level.
The absence of prick test reactions to the enzymes in the large numbers of consumers tested, many of whom were highly atopic and therefore likely to be readily sensitized, shows that at the present time clinical sensitivity has not been produced by the encapsulated enzyme preparations in use in the UK, containing twice the concentration used in the USA. This contrasts with the high incidence of sensitivity to the enzymes in allergic subjects reported by Bernstein (1972) in Cincinnati, though there are few other reports of clinical sensitivity, and in some of these nonencapsulated enzyme preparations were in use. It may be that the patients tested by Bernstein (1972) were heavily exposed to the B. subtilis enzyme preparations and indeed to papain and bovine ribonuclease as well, all of which gave a high incidence of reactions, especially in the highly atopic subjects.
The report by Stenius et al. (1971) that in tests with a nonspecific wealing agent, the histamine liberator 48/80, the sizes of the weals elicited correlated with the levels of total IgE suggests that in patients with high IgE levels the mast cells may be more sensitive, and so primed by exposure to the common allergens that nonspecific wealing agents could then elicit stronger reactions. This is supported by the findings of Vane (1971) that the lungs of sensitized guinea pigs liberate greater amounts of tissue mediators than those of nonsensitive guinea pigs in response to nonspecific stimuli.
The demonstration that levels of IgE antibody to the enzymes were higher in those subjects with greater use of the biological detergents, though below those of prick test and clinical reactivity as judged by the reactions of sensitized factory workers, makes it necessary to continue the observations on consumers. Nothing is known in the population in general about whether there are levels of IgE antibody to common allergens, below those which correlate with skin test and clinical sensitivity, but which can be correlated with differences in exposure, nor whether these lower levels are of clinical importance.
Dr Morris Greenberg (Employment Medical Advisory Service, Department ofEmployment, Baynards House, Chepstow Place, Westbourne Grove, London W2) Clinical Findings in Workers Exposed to the Enzymes ofBacillus subtilis Over the past thirty years the commercial applications and tonnage of enzyme preparations have increased, yet few cases of pulmonary sensitization in workers manufacturing enzymes have been reported (Simon & Pollak 1969 , Zweiman et al. 1967 .
Within a year from when a factory started the compounding of washing powder with a commercial derivative of B. subtilis containing proteolytic enzyme, reported respiratory illness among workers involved that could not be attributed entirely to an irritant effect of the compounds. Among the symptoms were dyspnoea, cough, chest pain or tightness, and general malaise. Dyspnoea occurred with or without wheezing, was acute in onset, often very severe and accompanied by angor animi lasting hours, days or months. The cough, which was nonproductive or produced scanty mucoid sputum, lasted for days or weeks. The onset of symptoms might follow exposure closely or be delayed for eight hours. With the assistance of the mechanism was demonstrated as due to a complex of immediate and late allergic reactions in bronchi and peripheral lung tissues. A series of reports on workers at detergent factories compounding B. subtilis derivative followed, including Gaffuri et al. (1970) , , Franz et al. (1971) and .
The severity of symptoms and signs in the individual studies appeared to relate to the extent of atmospheric contamination with B. subtilis derivative. Signs and symptoms were more common in the workers with positive skin reactions to subtilis extract but they also occurred in those with negative skin reactions. There was agreement with the immediate and delayed response to exposure, whether occupational or on bronchial challenge in hospital. reported on studies at two plants: one at which there had been heavy exposure to B. subtilis derivative, where the experience was much as elsewhere; and another where environmental hygiene was better and where after six months, despite the development of skin test positivity in a substantial number of workers, there was no evidence of pulmonary or bronchial disease.
The Department of Employment, with the assistance of Professor J Pepys and the Department of Clinical Immunology, Institute of Diseases of the Chest, studied over a period of three years a group of workers at a detergent factory where dramatic complaints were not being observed after an initial outbreak. The initial report showed that in workers with a positive prick test to B. subtilis extract the ventilatory capacity was reduced in 44%, compared with 14% in prick test negative subjects. Subsequent observations , carried out while considerable environmental improvement was taking place, showed that whereas initially atopic subjects predominated among prick test positive workers, subsequently the rate of prick test positivity rose in the nonatopic. Insofar as respiratory symptoms increased over the course of the survey, this was more rapid in smokers and those workers with other dust exposures prior to enzyme work. Over the period of observation the mean of values for the ratio of observed to expected (Cotes et al. 1966 ) FEV1 for all readings was 91.47%, with a tendency for overall improvement. However, the overall ratio of observed to expected FEV1 decreased for subjects with positive prick tests to B. subtilis reagent.
A complementary study by the Department of a group of ostensibly uncomplaining workers manufacturing enzymes including B. subtilis derivatives (unpublished) showed similarly that in the prick test positive subjects, the mean ratio of observed to expected FEV1 was lower than that for prick test negative subjects and decreasing at a more rapid rate.
Workers in the detergent industry exposed to B. subtilis derivative under high standards of hygiene may develop skin positivity to B. subtilis in the absence of overt symptoms or lung function signs. Fletcher (1970) cautioned against an oversanguine attitude until the significance of sensitization in relation to loss of pulmonary function has been studied for at least five years. A cooperative study by the soap and detergent industry and the Department of Employment is proceeding to evaluate the current industry hygiene standard (Soap and Detergent Industry Association 1971).
